Cynosure’s Picosure received US Food and Drug Administration (FDA) 510(k) clearance for the treatment of acne scars using the FOCUS lens array, a new disposable energy delivery system.
The FOCUS lens array microscopically concentrates laser energy on small treatment areas of tissue while stimulating collagen production and remodeling to build up depressed scars.
In the clinical trial that led to the new indication, 77% of patients achieved greater than 50% improvement (as graded by the physician). In addition, PicoSure scored a 97% physician satisfaction rate at the 1-month follow-up, and this increased to 100% at the 3-month visit. PicoSure received 76% patient satisfaction rate at the 1-month follow up and increased to 86% patient satisfaction rate at 3 months, the study showed.
Tat Regret Triumph
This same laser revolutionized tattoo removal when it was approved by the FDA in 2012, and was shown to be eradicating greens, blues, and other hard-to-erase colors in fewer sessions than older lasers.